Vigil Neuroscience, Inc. (VIGL)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch VIGL
See up to 3 months of VIGL. The 7-day demo opens the 1M and 3M ranges and puts VIGL on your watchlist.
Start 7-day demoLatest VIGL insider trades
About Vigil Neuroscience, Inc. (VIGL)
Vigil Neuroscience, Inc. is an SEC registrant, filing under CIK 0001827087, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
VIGL Form 4 activity by transaction type, last 90 days
No Form 4 activity for VIGL in the last 90 days.
VIGL insider transactions (Form 4)
7716 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Petra Kaufmann - Officer | Derivative | Stock Option Award (Right to Buy) | 144,000 | - | - | |
| Petra Kaufmann - Officer | Derivative | Stock Option Award (Right to Buy) | 330,000 | - | - | |
| Haeberlein Samantha L. Budd | Derivative | Common Stock | 5,000 | - | - | |
| Haeberlein Samantha L. Budd | Derivative | Common Stock | 12,000 | - | - | |
| Haeberlein Samantha L. Budd | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Haeberlein Samantha L. Budd | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Haeberlein Samantha L. Budd | Derivative | Stock Option Award (Right to Buy) | 30,694 | - | - | |
| David L. F. Gray - Officer | Derivative | Stock Option Award (Right to Buy) | 125,000 | - | - | |
| David L. F. Gray - Officer | Derivative | Stock Option Award (Right to Buy) | 125,000 | - | - | |
| David L. F. Gray - Officer | Derivative | Stock Option Award (Right to Buy) | 267,000 | - | - | |
| Gerhard Koenig | Derivative | Common Stock | 5,000 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 18,029 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 6,954 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 36,690 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 4,351 | - | - | |
| Gerhard Koenig | Derivative | Stock Option Award (Right to Buy) | 12,155 | - | - | |
| Stefan Vitorovic | Derivative | Common Stock | 5,000 | - | - | |
| Stefan Vitorovic | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Stefan Vitorovic | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Stefan Vitorovic | Derivative | Stock Option Award (Right to Buy) | 12,155 | - | - | |
| Atlas Venture Fund XII, L.P. | Derivative | Common Stock | 4,808,896 | - | - | |
| Atlas Venture Fund XII, L.P. | Derivative | Common Stock | 1,027,978 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Common Stock | 4,000 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 49,968 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 119,923 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 96,051 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 21,635 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 156,000 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 156,000 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 110,000 | - | - | |
| Jennifer Lynn Ziolkowski - Officer | Derivative | Stock Option Award (Right to Buy) | 135,000 | - | - | |
 Suzanne Louise Bruhn | Derivative | Common Stock | 5,000 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 24,073 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 33,875 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 24,310 | - | - | |
| Suzanne Louise Bruhn | Derivative | Stock Option Award (Right to Buy) | 6,235 | - | - | |
 Bruce Booth | Derivative | Common Stock | 5,000 | - | - | |
| Bruce Booth | Derivative | Common Stock | 4,808,896 | - | - | |
| Bruce Booth | Derivative | Common Stock | 1,027,978 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 7,577 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 12,155 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 9,713 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 34,612 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Bruce Booth | Derivative | Stock Option Award (Right to Buy) | 48,393 | - | - | |
| Cheryl R. Blanchard | Derivative | Common Stock | 5,000 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 24,761 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 24,984 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 36,690 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 5,017 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 12,155 | - | - | |
| Cheryl R. Blanchard | Derivative | Stock Option Award (Right to Buy) | 6,432 | - | - | |
 Mary Thistle | Derivative | Common Stock | 5,000 | - | - | |
| Mary Thistle | Derivative | Stock Option Award (Right to Buy) | 18,068 | - | - | |
| Mary Thistle | Derivative | Stock Option Award (Right to Buy) | 13,928 | - | - | |
| Mary Thistle | Derivative | Stock Option Award (Right to Buy) | 24,309 | - | - | |
| Mary Thistle | Derivative | Stock Option Award (Right to Buy) | 12,155 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 282,000 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Common Stock | 222,687 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 369,351 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 210,629 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 405,494 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 43,271 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 370,000 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 463,000 | - | - | |
| Ivana Magovcevic-Liebisch - Officer | Derivative | Stock Option Award (Right to Buy) | 485,000 | - | - | |
| Haeberlein Samantha L. Budd | Open-market purchase | Common Stock | 12,000 | $1.71 | $21K | |
| Ivana Magovcevic-Liebisch - Officer | Open-market purchase | Common Stock | 5,000 | $1.68 | $8K | |
| Ivana Magovcevic-Liebisch - Officer | Open-market purchase | Common Stock | 5,000 | $1.67 | $8K | |
| Ivana Magovcevic-Liebisch - Officer | Open-market purchase | Common Stock | 5,000 | $2.34 | $12K |
VIGL insider trading FAQ
What is the latest insider trade for VIGL?
Vigil Neuroscience, Inc. (VIGL) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-05. The full record for VIGL runs to 16 Form 4 filings, the earliest from 2024-12-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VIGL stock?
No insider purchases of VIGL were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling VIGL stock?
No insider sales of VIGL were filed in the last 90 days.
Where can I see VIGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VIGL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Petra Kaufmann view on EDGAR
- - Haeberlein Samantha L. Budd view on EDGAR
- - David L. F. Gray view on EDGAR
- - Gerhard Koenig view on EDGAR
- - Stefan Vitorovic view on EDGAR
- - Atlas Venture Fund XII, L.P. view on EDGAR
- - Jennifer Lynn Ziolkowski view on EDGAR
- - Suzanne Louise Bruhn view on EDGAR
- - Bruce Booth view on EDGAR
- - Cheryl R. Blanchard view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VIGL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VIGL with a 7-day demo
- VIGL on your watchlist
- Every VIGL Form 4 filing on record
- Up to 3 months of VIGL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.